Synchron Systems High Sensitivity Cardiac C-Reactive Protein (CRPH) Reagent

FDA 510(k) K070626 · Beckman Coulter, Inc.

Substantially Equivalent

510(k) numberK070626

Submission

Device name
Synchron Systems High Sensitivity Cardiac C-Reactive Protein (CRPH) Reagent
Applicant
Beckman Coulter, Inc.
Brea, CA, US
Received
March 6, 2007
Decision date
May 4, 2007
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
NQD – Cardiac C-Reactive Protein, Antigen, Antiserum, And Control
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5270
Specialty
Immunology

In vitro diagnostic test to measure C-reactive protein for the purpose of making cardiac risk assessments.

Other 510(k)s with product code NQD

510(k)DeviceApplicantDecision
K260026Tina-quant Cardiac high sensitivity CRP IIINQD · Traditional Roche Diagnostics04/02/2026SE
K233242Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2)NQD · Traditional Siemens Healthcare Diagnostics, Inc.01/18/2024SE
K212559CardioPhase® hsCRPNQD · Special Siemens Healthcare Diagnostics Products GmbH12/16/2022SE
K173833CRP VarioNQD · Traditional SENTINEL CH. SpA09/27/2018SE
K081294Advia Chemistry Cardiophase High Sensitivity C-Reactive Protein (Hscrp), CalibratorsNQD · Traditional Siemens Healthcare Diagnostics, Inc.07/29/2008SE
K071002Immage Immunochemistry Systems High Sensitivity Cardiac C-Reactive Protein (CCRP) ReagentNQD · Traditional Beckman Coulter, Inc.06/21/2007SE
K071017Immulite 2500 High Sensitivity C-Reactive Protein, Models L5KCRP (200 Tests), L5KCRP…NQD · Special Siemens Medical Solutions Diagnostics05/02/2007SE
K062924Stratus CS Acute Care Cardiophase Hscrp TestpakNQD · Traditional Dade Behring, Inc.12/26/2006SE
K063057Immulite/Immulite 1000, Immulite 2000 High Sensitivity CRPNQD · Abbreviated Diagnostic Products Corporation12/22/2006SE
K061802Dimension Vista Cardiophase Hscrp Flex Reagent Cartridge, Protein 2 Calibrator, Hscrp…NQD · Traditional Dade Behring, Inc.09/11/2006SE

More from Dade Behring, Inc.

510(k)DeviceDecision
K252169Access BNP IINBC · Traditional 03/24/2026SE
K254059Access anti-HBc IgMSEI · Traditional 03/13/2026SE
K253687Access anti-HBc TotalSEI · Traditional 02/19/2026SE
K251995Access anti-HAV IgMLOL · Traditional 01/27/2026SE
K250588Access Rubella IgGLFX · Traditional 11/17/2025SE
K252580iQ200 SeriesLKM · Special 09/10/2025SE
K243846Access anti-HAVLOL · Traditional 09/09/2025SE
K243804MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL)…LTT · Traditional 08/20/2025SE
K250036MicroScan Dried Gram-Positive MIC/Combo Panels with Daptomycin (DAP) (0.06-32 µg/mL)LTT · Traditional 08/15/2025SE
K243483Access hsTnIMMI · Traditional 08/01/2025SE

Questions and answers

When was Synchron Systems High Sensitivity Cardiac C-Reactive Protein (CRPH) Reagent cleared by the FDA?

Synchron Systems High Sensitivity Cardiac C-Reactive Protein (CRPH) Reagent (K070626) received a 510(k) decision of Substantially Equivalent on May 4, 2007, 59 days after the submission was received.

What is the product code of K070626?

The FDA product code is NQD – Cardiac C-Reactive Protein, Antigen, Antiserum, And Control, a Class II (moderate risk) device regulated under 21 CFR 866.5270.